These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 21055184

  • 1. [Richter syndrome: report of a case].
    Chen DB, Song QJ, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):487-8. PubMed ID: 21055184
    [No Abstract] [Full Text] [Related]

  • 2. [CD5-positive cardiac intravascular diffuse large-B cell lymphoma: report of a case].
    He RQ, Chen G, Li ZY.
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):835-6. PubMed ID: 24507104
    [No Abstract] [Full Text] [Related]

  • 3. [Primary diffuse large B-cell lymphoma in uterine corpus: report of a case].
    Dong W, Cao L, Wang DS.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):270-2. PubMed ID: 21616007
    [No Abstract] [Full Text] [Related]

  • 4. [Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
    Chen DB, Wang Y, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):635-6. PubMed ID: 21092597
    [No Abstract] [Full Text] [Related]

  • 5. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM, Taniguchi H, Fukuhara S, Morikawa N, Munakata W, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Tsuda H.
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of ibrutinib in the treatment of Richter syndrome.
    Tsang M, Shanafelt TD, Call TG, Ding W, Chanan-Khan A, Leis JF, Nowakowski GS, Bowen D, Conte M, Schwager SM, Slager SL, Kay NE, Hanson CA, Parikh SA.
    Blood; 2015 Mar 05; 125(10):1676-8. PubMed ID: 25745187
    [No Abstract] [Full Text] [Related]

  • 7. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
    Deschamps L, Signate A, Delaunay C, Morales I, Warter A, Smadja D, Derancourt C.
    Eur J Dermatol; 2011 Mar 05; 21(1):114-5. PubMed ID: 21233067
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy.
    Walter E, Schmitt T, Dietrich S, Ho A, Witzens-Harig M.
    Leuk Lymphoma; 2012 Nov 05; 53(11):2290-2. PubMed ID: 22475324
    [No Abstract] [Full Text] [Related]

  • 9. [Intravascular large B-cell lymphoma: report of a case].
    Yu GH, Qu GM, Yao WD, Lang ZQ, Wang W.
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul 05; 38(7):488-9. PubMed ID: 19781202
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].
    Chu DT.
    Zhonghua Zhong Liu Za Zhi; 2010 Oct 05; 32(10):721-4. PubMed ID: 21163058
    [No Abstract] [Full Text] [Related]

  • 11. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S, Fujioka Y, Nakamura F, Ota S, Shinozaki A, Yamamoto G, Kamikubo Y, Nannya Y, Ichikawa M, Fukayama M, Kurokawa M.
    Pathol Int; 2011 Nov 05; 61(11):662-6. PubMed ID: 22029677
    [Abstract] [Full Text] [Related]

  • 12. Increased rituximab (R) doses eliminate increased risk and improve outcome of elderly male patients with aggressive CD20+ B-cell lymphomas: the SEXIE-R-CHOP-14 trial of the DSHNHL.
    Clin Adv Hematol Oncol; 2014 Aug 05; 12(8 Suppl 16):8-9. PubMed ID: 25768993
    [No Abstract] [Full Text] [Related]

  • 13. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A, Tam CS, Seymour JF.
    Leuk Lymphoma; 2013 Dec 05; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract] [Full Text] [Related]

  • 14. Conjunctival lymphoma in a child.
    Waisbourd M, Leibovitch I, Sayar D, Elhasid R.
    Cornea; 2011 May 05; 30(5):598-9. PubMed ID: 21107252
    [Abstract] [Full Text] [Related]

  • 15. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Li WS, Xie JL, Zhang M, Zhou XG.
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb 05; 42(2):128-9. PubMed ID: 23710923
    [No Abstract] [Full Text] [Related]

  • 16. Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma.
    Coiffier B, Salles G.
    Blood; 2004 Sep 01; 104(5):1584-5; author reply 1585-6. PubMed ID: 15317734
    [No Abstract] [Full Text] [Related]

  • 17. A treatment for activated B-cell-like DLBCL?
    Zinzani PL.
    Lancet Oncol; 2014 Aug 01; 15(9):916-7. PubMed ID: 25042201
    [No Abstract] [Full Text] [Related]

  • 18. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L, Wang W, Li X, Guo Y, Zhu X.
    Zhonghua Bing Li Xue Za Zhi; 2014 May 01; 43(5):307-12. PubMed ID: 25030862
    [Abstract] [Full Text] [Related]

  • 19. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
    Mondello P, Cuzzocrea S, Pitini V, Aloisi C, Mian M.
    Acta Oncol; 2015 Jun 01; 54(6):953-5. PubMed ID: 25831143
    [No Abstract] [Full Text] [Related]

  • 20. Anti-CD20 antibody therapy for B-cell lymphomas.
    Maloney DG.
    N Engl J Med; 2012 May 24; 366(21):2008-16. PubMed ID: 22621628
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.